Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript
Source: SeekingAlpha
2026-02-02 16:10:28 ET
Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 February 2, 2026 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript
Molecular Partners AG
NASDAQ: MOLN
MOLN Trading
0.3% G/L:
$5.0048 Last:
1,437 Volume:
$4.99 Open:
MOLN Latest News
February 26, 2026 01:00:00 am
Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics
February 26, 2026 01:00:00 am
Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results
MOLN Stock Data
$191,321,070
36,976,631
N/A
12
N/A
Biotechnology & Life Sciences
Healthcare
CH
Zurich-Schlieren
